Prolonged response to first-line erlotinib for advanced lung adenocarcinoma

<p>Abstract</p> <p>A 58-year-old, non-smoking female of Philippine origin presented with painful thoracic and neck nodal relapse of lung adenocarcinoma almost 5 years after left pneumonectomy for stage II non-small-cell lung cancer. She refused conventional chemotherapy or radiatio...

Full description

Bibliographic Details
Main Author: Copeman Michael
Format: Article
Language:English
Published: BMC 2008-11-01
Series:Journal of Experimental & Clinical Cancer Research
Online Access:http://www.jeccr.com/content/27/1/59